Daiwa Securities Group
CRMD icon

Daiwa Securities Group’s CorMedix CRMD Stock Holding History

Daiwa Securities Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$992K Hold
126,400
– – ﹤0.01% 826
2026
Q1 		$858K Buy
126,400
+126,200
+63,100% +$933K ﹤0.01% 808
2025
Q4 		$2K Hold
200
– – ﹤0.01% 1299
2025
Q3 		$2K Hold
200
– – ﹤0.01% 1261
2025
Q2 		$2K Hold
200
– – ﹤0.01% 1208
2025
Q1 		$1K Hold
200
– – ﹤0.01% 1219
2024
Q4 		$2K Buy
+200
New +$2K ﹤0.01% 1213

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Daiwa Securities Group's CRMD Position: Q2 2026 in Review

Daiwa Securities Group held its CorMedix (CRMD) position steady in Q2 2026 at 126,400 shares worth $992K. The position accounts for ﹤0.01% of the portfolio, ranked #826.

Daiwa Securities Group first reported a position in CRMD in Q4 2024 and has held it in 7 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Daiwa Securities Group held 126,400 shares of CorMedix worth $992K as of Q2 2026.
  • Daiwa Securities Group left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #826 holding.
  • Daiwa Securities Group first reported a position in CorMedix in Q4 2024 and has held it in 7 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.